Scientists at Lawrence Berkeley National Laboratory participated in developing a COVID-19 antibody therapy that could possibly neutralize all known SARS-CoV-2 strains. Jay Nix, beamline director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results